Please assess the completion status of the following clinical trial:

Trial Title: Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmed COVID-19 positive~* Admission to ICU or step-down unit~* Age ≥ 18 years old~Exclusion Criteria:~* Stage 3 AKI by KDIGO criteria~* CKD stage 4-5~* Contraindications to Na bicarbonate therapy (e.g. met. alkalosis, severe heart failure)~* Urine pH \> 7.0

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard of Care (Type: ACTIVE_COMPARATOR): Standard of Care treatment
- Sodium Bicarbonate (Type: ACTIVE_COMPARATOR): Sodium bicarbonate 225 mEq (225 mL of an 8.4% solution) intravenously over 1 hour. Sodium bicarbonate 8.4% solution should not exceed 900 ml (4 boluses) in 24 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).